Elk Creek Partners’s Halozyme HALO Stock Holding History

Elk Creek Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$11.8M	Buy	654,362 +15,492	+2%	+$294K	2.02%	9
2019 Q4	$11.3M	Sell	638,870 -119,683	-16%	-$2.07M	1.3%	20
2019 Q3	$11.8M	Sell	758,553 -51,402	-6%	-$847K	1.01%	37
2019 Q2	$13.9M	Buy	809,955 +21,254	+3%	+$343K	1.04%	26
2019 Q1	$12.7M	Buy	788,701 +47,885	+6%	+$776K	0.92%	36
2018 Q4	$10.8M	Buy	740,816 +139,123	+23%	+$2.22M	0.9%	37
2018 Q3	$10.9M	Buy	+601,693	New	+$10.5M	0.59%	79

Other funds holding HALO

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return

Elk Creek Partners's HALO Position: Q1 2020 in Review

Elk Creek Partners increased its Halozyme (HALO) stake by 2.4% in Q1 2020, buying an estimated $294K and bringing the position to 654,362 shares worth $11.8M. The position accounts for 2.02% of the portfolio, ranked #9.

Elk Creek Partners first reported a position in HALO in Q3 2018 and has held it in 7 quarters since. The position peaked at $13.9M in Q2 2019. 210 funds tracked by Wall St. Rank hold HALO as of Q1 2020.

Elk Creek Partners held 654,362 shares of Halozyme worth $11.8M as of Q1 2020.
Elk Creek Partners bought 15,492 Halozyme shares in Q1 2020, an estimated $294K.
Halozyme made up 2.02% of Elk Creek Partners's portfolio in Q1 2020, its #9 holding.
Elk Creek Partners first reported a position in Halozyme in Q3 2018 and has held it in 7 quarters since.
Elk Creek Partners's Halozyme position peaked at $13.9M in Q2 2019.
210 funds tracked by Wall St. Rank held Halozyme as of Q1 2020.

Based on Elk Creek Partners's 13F filing for Q1 2020, filed 14 May 2020.